Noninvasive detection of acute renal allograft rejection by measurement of soluble Tim-3 in urine

Chen,Dajin; Peng,Wenhan; Jiang,Hong; Yang,Hao; Wu,Jianyong; Wang,Huiping; Chen,Jianghua

doi:10.3892/mmr.2017.6670

Noninvasive detection of acute renal allograft rejection by measurement of soluble Tim-3 in urine

Authors:
- Dajin Chen
- Wenhan Peng
- Hong Jiang
- Hao Yang
- Jianyong Wu
- Huiping Wang
- Jianghua Chen
View Affiliations

Affiliations: Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China
Published online on: May 31, 2017 https://doi.org/10.3892/mmr.2017.6670
Pages: 915-921

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The purpose of the present study was to assess whether urinary soluble T-cell immunoglobulin and mucin domain-containing protein 3 (sTim-3) could be adopted as a novel non‑invasive biomarker for acute rejection (AR) following renal transplantation. A total of 156 patients were enrolled between January 2006 and December 2009, comprising 49 patients with biopsy‑proven AR, 58 patients with stable grafts and no abnormal histological findings (NO‑AR), 10 patients with subclinical rejection (SCR) in protocol biopsies, 10 patients with acute tubular necrosis (ATN) and 29 patients with chronic allograft nephropathy (CAN). Additionally, urine samples from 40 healthy individuals were also collected as controls. The urinary concentration of sTim‑3 was determined by ELISA in the 156 renal allograft recipients and 40 healthy controls. Compared with NO‑AR and healthy controls, patients with AR excreted urinary sTim‑3 at a significantly higher level (4,356±440.4, 95% CI: 3,473‑5,242 ng/mmol creatinine). Likewise, patients with ATN exhibited a significantly lower level of urinary sTim‑3 (2,060±217, 95% CI: 1,679‑2,680 ng/mmol creatinine) than patients with AR. The discriminatory value was measured by the area under the receiver operating characteristic curve (ROC), which had a value of 0.88 (95% CI: 0.809‑0.951), demonstrating that sTim‑3 was a suitable marker for the diagnosis of AR. At a cut-off point of 1,836 ng/mmol creatinine, the sensitivity was 89.8% and the specificity was 82.8% (P<0.001). Amongst the patients with AR, patients with steroid‑resistant acute rejection (n=31) had significantly higher urinary sTim‑3 concentrations than patients with steroid‑sensitive acute rejection (n=18; 5,548±613.5, 95%CI: 4,287‑6,809 ng/mmol creatinine vs. 2,653±391.7, 95% CI: 1,830‑3,476 ng/mmol creatinine; P=0.0002). No significant difference in urinary sTim‑3 was found between patients with AR and CAN (3,920±543.5, 95% CI: 3,473‑5,242 ng/mmol creatinine), and a significantly higher level of Tim‑3 was excreted by patients with CAN compared with patients with NO‑AR and healthy controls (P<0.001). The present study, therefore, suggests that urinary sTim‑3 may be used as a valuable non‑invasive biomarker for the detection of AR. In addition, urinary sTim‑3 levels were demonstrated to be associated with the response to anti‑rejection therapy. The results of the present study may provide support future research into the screening of novel immune suppressants.

View Figures

View References

1	Curtis JJ: End-stage renal disease patients: Referral for transplantation. J Am Soc Nephrol. 9:(12 Suppl). S137–S140. 1998.PubMed/NCBI
2	Karam VH, Gasquet I, Delvart V, Hiesse C, Dorent R, Danet C, Samuel D, Charpentier B, Gandjbakhch I, Bismuth H and Castaing D: Quality of life in adult survivors beyond 10 years after liver, kidney and heart transplantation. Transplantation. 76:1699–1704. 2003. View Article : Google Scholar : PubMed/NCBI
3	Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ and Stablein D: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 342:605–612. 2000. View Article : Google Scholar : PubMed/NCBI
4	Meier-Kriesche HU, Schold JD, Srinivas TR and Kaplan B: Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant. 4:378–383. 2004. View Article : Google Scholar : PubMed/NCBI
5	Beckingham IJ, Nicholson ML and Bell PR: Analysis of factors associated with complications following renal transplant needle core biopsy. Br Urol. 73:13–15. 1994. View Article : Google Scholar
6	Thongboonkerd V, Mcleish KR, Arthur JM and Klein JB: Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation. Kidney Int. 62:1461–1469. 2002. View Article : Google Scholar : PubMed/NCBI
7	Pieper R, Gatlin CL, Mcgrath AM, Makusky AJ, Mondal M, Seonarain M, Field E, Schatz CR, Estock MA, Ahmed N, et al: Characterization of the human urinary proteome: A method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics. 4:1159–1174. 2004. View Article : Google Scholar : PubMed/NCBI
8	Hauser IA, Spiegler S, Kiss E, Gauer S, Sichler O, Scheuermann EH, Ackermann H, Pfeilschifter JM, Geiger H, Gröne HJ and Radeke HH: Prediction of acute renal allograft rejection by urinary monokine induced by IFN-gamma (MIG). J Am Soc Nephrol. 16:1849–1858. 2005. View Article : Google Scholar : PubMed/NCBI
9	Muthukumar T, Dadhania D, Ding R, Snopkowski C, Naqvi R, Lee JB, Hartono C, Li B, Sharma VK, Seshan SV, et al: Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med. 353:2342–2351. 2005. View Article : Google Scholar : PubMed/NCBI
10	O'Riordan E, Orlova TN, Mei JJ, Butt K, Chander PM, Rahman S, Mya M, Hu R, Momin J, Eng EW, et al: Bioinformatic analysis of the urine proteome of acute allograft rejection. J Am Soc Nephrol. 15:3240–3248. 2004. View Article : Google Scholar : PubMed/NCBI
11	Peng W, Chen J, Jiang Y, Wu J, Shou Z, He Q, Wang Y, Chen Y and Wang H: Urinary fractalkine is a marker of acute rejection. Kidney Int. 74:1454–1460. 2008. View Article : Google Scholar : PubMed/NCBI
12	Peng W, Chen J, Jiang Y, Shou Z, Chen Y and Wang H: Acute renal allograft rejection is associated with increased levels of vascular endothelial growth factor in the urine. Nephrology (Carlton). 13:73–79. 2008.PubMed/NCBI
13	D'elios MM, Josien R, Manghetti M, Amedei A, de Carli M, Cuturi MC, Blancho G, Buzelin F, del Prete G and Soulillou JP: Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts. Kidney Int. 51:1876–1884. 1997. View Article : Google Scholar : PubMed/NCBI
14	Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, Manning S, Greenfield EA, Coyle AJ, Sobel RA, et al: Th-1 specific cell surface protein TIM-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 415:536–541. 2002. View Article : Google Scholar : PubMed/NCBI
15	Kuchroo VK, Umetsu DT, DeKruyff RH and Freeman GJ: The TIM gene family: Emerging roles in immunity and disease. Nat Rev Immunol. 3:454–462. 2003. View Article : Google Scholar : PubMed/NCBI
16	Sabatos CA, Chakravarti S, Cha E, Schubart A, Sánchez-Fueyo A, Zheng XX, Coyle AJ, Strom TB, Freeman GJ and Kuchroo VK: Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol. 4:1102–1110. 2003. View Article : Google Scholar : PubMed/NCBI
17	Sánchez-Fueyo A, Tian J, Picarella D, Domenig C, Zheng XX, Sabatos CA, Manlongat N, Bender O, Kamradt T, Kuchroo VK, et al: TIM-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol. 4:1093–1101. 2003. View Article : Google Scholar : PubMed/NCBI
18	Khademi M, Illés Z, Gielen AW, Marta M, Takazawa N, Baecher-Allan C, Brundin L, Hannerz J, Martin C, Harris RA, et al: T cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and tim-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple screrosis. J Immunol. 172:7169–7176. 2004. View Article : Google Scholar : PubMed/NCBI
19	Wu JY, Chen JH, Wang YM, He Q and Wu DB: Improved clinical outcomes in Chinese renal allograft recipients receiving lower dose immunosuppressants. Transplantation. 78:713–718. 2004. View Article : Google Scholar : PubMed/NCBI
20	Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, et al: The Banff 97 working classification of renal allograft pathology. Kidney Int. 55:713–723. 1999. View Article : Google Scholar : PubMed/NCBI
21	Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka MJ, Cosyns JP, Demetris AJ, Fishbein MC, et al: Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant. 3:708–714. 2003. View Article : Google Scholar : PubMed/NCBI
22	Wang F, He W, Yuan J, Wu K, Zhou H, Zhang W and Chen ZK: Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. Transpl Immunol. 19:12–29. 2008. View Article : Google Scholar : PubMed/NCBI
23	Renesto PG, Ponciano VC, Cenedeze MA, Saraiva Câmara NO and Pacheco-Silva A: High expression of Tim-3 mRNA in urinary cells from kidney transplant recipients with acute rejection. Am J Transplant. 7:1661–1665. 2007. View Article : Google Scholar : PubMed/NCBI
24	Escobedo-Villarreal MM, Mercado-Moreira AB, Muñoz-Espinosa LE, Gamboa-Esparza M, Pérez-Rodríguez E and Cordero-Pérez P: Urinary protein detection by iTRAQÒ associated with renal transplant complications and its modification with therapy. Cir Cir. 83:393–401. 2015. View Article : Google Scholar : PubMed/NCBI
25	Ghys LF, Paepe D, Taffin ER, Vandermeulen E, Duchateau L, Smets PM, Delanghe J and Daminet S: Serum and urinary cystatin C in cats with feline immunodeficiency virus infection and cats with hyperthyroidism. J Feline Med Surg. 18:658–665. 2016. View Article : Google Scholar : PubMed/NCBI
26	Yamada T, Arakawa Y, Mii A, Kashiwagi T, Kaneko T, Utsumi K, Masuda Y, Shimizu A, Iino Y and Katayama Y: A case of monoclonal immunoglobulin G1-lambda deposition associated with membranous feature in a patient with hepatitis C viral infection. Clin Exp Nephrol. 16:468–472. 2012. View Article : Google Scholar : PubMed/NCBI
27	Mäkelä S, Mustonen J, Ala-Houhala I, Hurme M, Koivisto AM, Vaheri A and Pasternack A: Urinary excretion of interleukin-6 correlates with proteinuria in acute Puumala hantavirus-induced nephritis. Am J Kidney Dis. 43:809–816. 2004. View Article : Google Scholar : PubMed/NCBI